Glaukos (GKOS) Shares Outstanding (Weighted Average) (2013 - 2026)

Glaukos (GKOS) reported Shares Outstanding (Weighted Average) of $58.0 million for Q1 2026, up 2.45% year-over-year from $56.6 million in Q1 2025, and up 1.45% quarter-over-quarter from $57.2 million in Q4 2025.

Glaukos (GKOS) Shares Outstanding (Weighted Average) (2013 - 2026) Analysis & Trends

Glaukos (GKOS) has 14 years of Shares Outstanding (Weighted Average) data on file, last reported at $58.0 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $58.0 million, up 2.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $58.0 million (up 2.45% YoY), and the FY2025 annual result was $57.2 million, up 8.41% from the prior year.
  • Shares Outstanding (Weighted Average) grew to $58.0 million in Q1 2026 per GKOS's latest filing, from $57.2 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $58.0 million in Q1 2026 and troughed at $47.0 million in Q1 2022.
  • A 5-year average of $51.6 million and a median of $49.6 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) rose 1.41% in 2023, then gained 14.23% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $47.4 million in 2022, then climbed by 2.08% to $48.4 million in 2023, then increased by 8.92% to $52.8 million in 2024, then grew by 8.41% to $57.2 million in 2025, then advanced by 1.45% to $58.0 million in 2026.
  • Business Quant data shows GKOS's Shares Outstanding (Weighted Average) at $58.0 million in Q1 2026, $57.2 million in Q4 2025, and $57.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.74 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 382.90 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 579.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 385.10 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 456.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 98.20 Mn
10 Glaukos 7.55 Bn 7.45 Bn 117.23 Mn 58.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 58.02 Mn
Dec 31, 2025 57.19 Mn
Sep 30, 2025 57.40 Mn
Jun 30, 2025 57.21 Mn
Mar 31, 2025 56.64 Mn
Dec 31, 2024 52.76 Mn
Sep 30, 2024 55.04 Mn
Jun 30, 2024 50.72 Mn
Mar 31, 2024 49.58 Mn
Dec 31, 2023 48.43 Mn
Sep 30, 2023 48.28 Mn
Jun 30, 2023 48.28 Mn
Mar 31, 2023 47.88 Mn
Dec 31, 2022 47.44 Mn
Sep 30, 2022 47.61 Mn
Jun 30, 2022 47.21 Mn
Mar 31, 2022 47.05 Mn
Dec 31, 2021 46.42 Mn
Sep 30, 2021 46.26 Mn
Jun 30, 2021 46.31 Mn